In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
about
Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strainsCytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host.Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion.Human cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation.Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipientsDiagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics.Cytomegalovirus encodes a potent alpha chemokine.Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.Genomes of the endothelial cell-tropic variant and the parental Toledo strain of human cytomegalovirus are highly divergent.Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus.Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines.Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytesHuman cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.Endothelial cells and CMV dissemination.Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytesDissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
P2860
Q24798984-71108301-B4A1-4BAC-9524-C1C3E5D06EF6Q28141501-6583657B-E0CD-431C-AA03-18E33F29E9ECQ30478992-AA244779-BA44-4030-A9BA-609E7F5290DBQ33558361-718A6FDA-F236-468E-BC00-B45B911331A4Q33843302-ED7E33E2-2252-4525-95BD-78746CF9FA38Q33946557-72CB7B26-3330-4B00-8473-BB5E12433CF3Q33966910-F25E11ED-2FD8-48E3-A635-3873CD319723Q34102747-583B18D0-06A5-4D6A-946C-12B1411418A0Q34263661-04AEC0DE-5CCE-4B75-AED4-75D8A97C9B24Q34345137-01FE4D8B-3BB0-4709-A613-1604020A52DDQ36436978-5975971D-0071-46F1-8A3F-971AB38C7332Q37073289-F3A39D91-3001-4598-A239-490BD612E906Q38889869-556F80C2-25A1-4972-B132-A458AAAC0FD7Q39020964-0488ACAB-30BC-4257-B2D6-D77DA796B38DQ39403005-8421AEB4-1CE0-428F-B24D-10D85C8021F4Q39467685-72D59BBA-445B-4AFA-9DFE-F2C46ED1550BQ39555791-AADB9613-6396-4D3F-8660-E590FB3D4001Q39591457-2AC0A3E5-F3A4-4E35-B8A4-C6D33CFEECD8Q39637767-4DAC9414-6FC3-46BE-9D3E-46314DC63433Q39960937-01176E1C-3789-46AF-AE9B-596A157C20B0Q39997572-798DC3F0-E46B-4ED3-BEA5-7A08FEAE13C0Q40925445-80EB13A2-9F8C-4C0A-82BD-C0ACFBAB7323Q41581885-9A2EF859-B758-4230-8A88-48EBC5BD7B94
P2860
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
@en
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.
@nl
type
label
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
@en
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.
@nl
prefLabel
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
@en
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.
@nl
P2093
P2860
P356
P1476
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
@en
P2093
P2860
P304
P356
10.1172/JCI1633
P407
P577
1998-06-01T00:00:00Z